A Look Back
Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. I had a first-hand role in raising money from Wall Street by being part of an IPO roadshow as Synta went public in 2007.
Let's personalize your content